Lucas Alessandro

Lucas Alessandro

Auto-generated profile, based on publicly available information

Lucas Alessandro

Neurology

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2018 in Journal of the Peripheral Nervous System
Verified
Journal Article
Closed access
PDF file
LALucas Alessandro
Lucas Alessandro
JRJosé M. Pastor Rueda
José M. Pastor Rueda
MWMiguel Wilken
Miguel Wilken
LQLuis Querol
Luis Querol
MMMariano Marrodán
Mariano Marrodán
MFMauricio F. Farez
Mauricio F. Farez

1 January 2019 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
LALucas Alessandro
Lucas Alessandro
ICIsmael L. Calandri
Ismael L. Calandri
MSMarcos Fernández Suarez
Marcos Fernández Suarez
MHMaría L. Heredia
María L. Heredia
HCHernán Chaves
Hernán Chaves
MFMauricio F. Farez
Mauricio F. Farez
The risk of recurrence of new amnesia events in patients having previously experienced transient global amnesia (TGA) ranges between 2.9-23.8%. Objective: Our objective was to search for recurrence predictors in TGA patients. Methods: Retrospective analysis to identify recurrence predictors in a cohort of 203 TGA patients from a single center in Buenos Aires, Argentina, diagnosed between January 2011 and March 2017 Clinical features and complementary studies (laboratory results, jugular vein Doppler ultrasound and brain MRI) were analyzed. Comparison between patients with recurrent versus single episode TGA was performed, applying a multivariate logistic regression model. Results: Mean age at presentation was 65 years (20-84); 52% were female. Median time elapsed between symptom onset and ER visit was two hours, with the average episode duration lasting four hours. Mean follow-up was 22 months. Sixty-six percent of patients referred to an identifiable trigger. Jugular reflux was present in 66% of patients; and 22% showed images with hippocampus restriction on diffusion-weighted MRI. Eight percent of patients had TGA recurrence. Patients with recurrent TGA had a more frequent history of migraine than patients without recurrence (37.5% vs. 14%; p = 0.03). None of the other clinical characteristics and complementary studies were predictors of increased risk of recurrence. Conclusions: Patients with migraine may have a higher risk of recurrent TGA. None of the other clinical characteristics evaluated allowed us to predict an increased risk of recurrence. Although the complementary studies allowed us to guide the diagnosis, they did not appear to have a significant impact on the prediction of recurrence risk.

1 June 2020 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
LALucas Alessandro
Lucas Alessandro
MRMario Ricciardi
Mario Ricciardi
HCHernán Chaves
Hernán Chaves
RARicardo F. Allegri
Ricardo F. Allegri

1 December 2018 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
MMMariano Marrodan
Mariano Marrodan
JAJ.N. Acosta
J.N. Acosta
LAL. Alessandro
L. Alessandro
VFV.C. Fernandez
V.C. Fernandez
ECE. Carnero Contentti
E. Carnero Contentti
JCJ. Correale
J. Correale

1 July 2017 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
MMMariano Marrodan
Mariano Marrodan
JCJorge Correale
Jorge Correale
LALucas Alessandro
Lucas Alessandro
MAMariela Amaya
Mariela Amaya
MFMaria Eugenia Fracaro
Maria Eugenia Fracaro
MFMarcela Fiol
Marcela Fiol

1 May 2022 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
LALucas Alessandro
Lucas Alessandro
JCJuan Ignacio Castiglione
Juan Ignacio Castiglione
PBPatricio Brand
Patricio Brand
VBVeronica Bruno
Veronica Bruno
FBFabio Barroso
Fabio Barroso
Background: A treatment-related fluctuation (TRF) in a patient with Guillain-Barré syndrome (GBS) is defined as clinical deterioration within two months of symptom onset following previous stabilization or improvements with treatment. Objective: To investigate the clinical characteristics and factors that could increase the risk of relapse of GBS in patients with and without TRFs. Methods: Retrospective review of medical records of patients (>18 years) with GBS evaluated between January/2006 and July/2019. Demographic and clinical characteristics, ancillary studies, treatment received, and the clinical course of patients with and without TRFs were analyzed. Results: Overall, 124 cases of GBS were included; seven (5.6%) presented TRFs. GBS-TRF cases were triggered more frequently by infectious mononucleosis (28.57 vs. 8.55%; p=0.01). GBS-TRF were initially treated with plasmapheresis more frequently than those without TRF (14.29 vs. 1.70%; p=0.0349). Combined treatment (71.43 vs. 4.27%; p<0.001) and corticosteroids (42.86 vs. 1.71%; p<0.001) were more commonly used in the GBS-TRF group. GBS-TRF patients presented a higher median initial disability score (4 vs. 2; p=0.01). Conclusions: Patients with GBS triggered by infectious mononucleosis and a high degree of initial disability have higher chances of developing TRFs. Although patients with TRF were treated with plasmapheresis more often, the total number was too low to suggest a link between plasma exchange and TRF.